SCHEMBL16447402

SCHEMBL16447402

Cc1ncnc2cnc(C(N)=O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.40
SIRT6 Q8N6T7 2/20 0.38
ADORA3 P0DMS8 1/20 0.34
TSHR P16473 1/20 0.34
MC4R P32245 1/20 0.34
ADRA1A P35348 1/20 0.34
MC3R P41968 1/20 0.34
GRM2 Q14416 4/20 0.33
PI4K2A Q9BTU6 4/20 0.33
KMT2A Q03164 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
LMNA P02545 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
PI4KB Q9UBF8 1/20 0.32
SIRT2 Q8IXJ6 2/20 0.32
SIRT1 Q96EB6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31712846 0.77 LCK (0.40) LCKSIRT6ADORA3TSHRMC4R
SCHEMBL15565679 0.74 LCK (0.42) LCKSIRT6ADORA3TSHRMC4R
SCHEMBL17804471 0.73 EGFR (0.50)
SCHEMBL15691462 0.72 UHRF1 (0.35) TSHRLMNA
SCHEMBL21305276 0.70 MAP4K4 (0.33) TSHRLMNA
SCHEMBL30625387 0.70 NOS3 (0.48) LCKSIRT6ADORA3TSHRMC4R
SCHEMBL16447570 0.70 KDM4E (0.44) KMT2A
SCHEMBL24121646 0.69 EGFR (0.31)
SCHEMBL13712399 0.69 EGFR (0.43)
SCHEMBL29925974 0.69 LCK (0.45) LCKSIRT6ADORA3TSHRMC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771351-B2 Wnt signaling inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-09-26 US disclosed
US-9771351-B2 Wnt signaling inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-09-26 US disclosed
US-20160168125-A1 WNT SIGNALING INHIBITOR KYOWA HAKKO KIRIN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160168125-A1 WNT SIGNALING INHIBITOR KYOWA HAKKO KIRIN CO., LTD. (JP) 2016-06-16 US disclosed
EP-3028703-A1 Wnt SIGNALING INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2016-06-08 EP disclosed
WO-2015016195-A1 Wnt SIGNALING INHIBITOR 協和発酵キリン株式会社 (JP) 2015-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168125-A1 WNT SIGNALING INHIBITOR WNT3A, WNT1, WNT3 LCK 2334/4885SIRT6 3863/4885ADORA3 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.